Three Top Short Squeeze Candidates For This Week

We post our DD here are some of our posts have been censored on Wallstreetbets due to the $1 billion market cap requirement. We would like to remind people that we were the first to announce SPRT as a top short squeeze candidate when it was trading at just $2.68 in May. It had just a $68 million market cap at the time and is now a WSB darling at three times the price. We are announcing here the three stocks that we think make top short squeeze candidates for the rest of the week. 

#1 Travere Therapeutics, Inc. (TVTX):

Shorts are in big trouble here. On Monday the company announced positive interim Phase 3 PROTECT study results with plans to submit a new drug application in the first half of 2022. The stock initially broke over $20 at market open but sunk to close at $17.82, up 15% on the day. Usually that would be a bearish sign but trading has been strong on Tuesday, as the stock is up 7% to about $19.00 in mid-afternoon trading. Volume has dissipated substantially from Monday's move, making short covering more difficult. 

Yahoo Finance data shows that there are 6.8 million shorts on a float of 41.2 million, approximately 16.5% short interest. Institutions hold 108.6% of the shares so shorts may find it increasing difficult to cover. If daily volume drops to 1-2 million shares a day, that makes it nearly impossible for them to exit their short position without creating a squeeze. 



























#2 BeyondSpring Inc. (BYSI):

BYSI had some great news, tripling on August 4th after its lung cancer treatment meets endpoints in Phase 3 trial. The stock price has been on a wild ride as shorts expected dilution, but no immediate dilution is in the plans. The stock price has pulled back to the low $20's, making it an ideal time for shorts to cover and minimize their losses, as well as an entry point for longs looking to buy in. 

Yahoo Finance data shows a short interest of 1.6 million on only 20.5 million shares outstanding for a short interest of 7.8%. 




























#3 Lightning eMotors, Inc. (ZEV):

ZEV spiked on a massive deal of up to $850 million with Forest River, a Berkshire Hathaway company and the largest shuttle bus manufacturer in North America. ZEV will be delivering 7,500 zero-emission Class 4 and Class 5 buses across the U.S. and Canada between 2021 and 2025. The initial reaction was very positive as the stock price soared to over $12. It has since pulled back to $8 post-earnings which represents a great buy in point as shorts will likely cover to minimize their losses from last week's major news. The company set a record for revenue, but growth was below very high expectations as it worked through supply chain issues. Those issues are now in the past. 

Yahoo Finance data shows that ZEV has 2.6 million shares short on 17.7 million float for a short interest of 14.7%. 





Comments

Post a Comment

Popular posts from this blog

The Two Best Biotech Short Squeeze Candidates And The Next Carvana

Image
With the market having recovered most of its recent drop to be near all-time highs once again, shorts have been destroyed and are in a desperate spot. Heavily shorted stocks like B. Riley Financial, Inc. (RILY), Globe Life Inc. (GL) and Carvana Co. (CVNA) have been on absolute tears. We have written about CVNA before , as well as the impact of CVNA's move on Root , Inc. (ROOT). When a stock is squeezing like CVNA, a related stock like ROOT will follow suit. Shorts are often shorting multiple related stocks. Most don't even hide it with Kerrisdale openly bragging about its poor track record. GL was another one that was attacked by shorts which we talked about as a gamma squeeze candidate that has worked out very well over the past three weeks.  In this market of short squeezes, we have identified two excellent biotech short squeeze candidates, ImmunityBio, Inc. (IBRX) and Soleno Therapeutics, Inc. (SLNO). IBRX is starting up the production and sale of its cancer drug ANKT...
Read more

The Next NVDA-Backed Runner and New Asian IPO Squeeze Play

Image
We have seen stocks like Super Micro Computer, Inc. (SMCI) and SoundHound AI, Inc. (SOUN) have incredible squeeze runs thanks to their connection to NVIDIA Corporation (NVDA). We think the next one will be Spire Global, Inc. (SPIR), which popped a week ago after it announced a collaboration with NVDA to enhance AI-driven weather prediction. A few day later it dropped on the announcement of a financing at $14, with the potential to raise $61 million if warrants at $14.50 are exercised. We think there is a good chance that NVDA got in on this financing, as it tends to invest in the companies it does these deals with when spreading AI across different sectors. One such recent example was with Recursion Pharmaceuticals, Inc. (RXRX) for AI in drug development.  It looks like SPIR didn't really need this financing as it has enough cash and looks like it will be cash flow and net income positive in 2024. This financing was of a strategic nature, not something led by broker...
Read more

Forget about CVNA, PLCE is the Next Major Short Squeeze Play

Image
 Back in June, we called out Kerrisdale Capital and its short on Carvana Co. (CVNA) in our piece " Carvana: The Gamma Squeeze is Real, Time to Bankrupt Kerrisdale ". Kerrisdale has a history of calling one bad short after another, creating a squeeze on all of its positions as the firm and its associates face liquidity crises. Kerrisdale is once again on a cold streak as its short on Altimmune, Inc. (ALT) simultaneously blew up just as CVNA headed from $70 to $80 this week.  However, we think CVNA is done for now. Recall that in June after the initial spike to nearly $30, the stock pulled back to $20 before hitting $40 in the next month. People who are riding weekly call options aren't likely to cash in. CVNA looks headed to the mid to low $60's to close the gap that currently exists in the $62 to $66 area before resuming any further rise. Kerrisdale created an artificial short squeeze with its report, but now that both ALT and CVNA have come down from their weekly hig...
Read more